Daratumumab: A Review in Combination Therapy for Transplant-Eligible Newly Diagnosed Multiple Myeloma

Lamb, YN

Lamb, YN (corresponding author), Springer Nat, Private Bag 65901, Auckland 0754, New Zealand.

DRUGS, 2020; 80 (14): 1455

Abstract

Intravenous daratumumab (DARZALEX (R)), a human monoclonal antibody targeting CD38, is approved in the EU and USA for use in combination with bortezom......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索